Sarda Proteins Ltd Stock Price Today (NSE: SRDAPRT)

Sarda Proteins Ltd

SRDAPRTEdible Oil
88.70+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Sarda Proteins Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Sarda Proteins Ltd share price today is 88.70, up +0.00% on NSE/BSE as of 19 June 2026. Sarda Proteins Ltd (SRDAPRT) is a Small-cap company in the Edible Oil sector with a market capitalisation of 13.84 (Cr). The 52-week high for SRDAPRT share price is 144.30 and the 52-week low is 59.95. The company has a Return on Equity (ROE) of 0.42% and a debt-to-equity ratio of 0.07.

Sarda Proteins Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
88.70
Low
84.48
Volume
439.4
Change
+5.00%

Sarda Proteins Ltd share price chart: 5.00% return over the past month. 52-week high ₹144.30, 52-week low ₹59.95.

Sarda Proteins Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
88.7088.7088.7088.7017.00 (Cr)
88.7088.7088.7088.700.00 (Cr)
88.7088.7088.7088.700.00 (Cr)
88.7088.7088.7088.700.00 (Cr)
88.7088.7088.7088.700.00 (Cr)
88.7088.7088.7088.7020.00 (Cr)
88.7088.7088.7088.70133.00 (Cr)
88.7088.7088.7088.701.64K (Cr)
84.4884.4884.4884.48243.00 (Cr)
84.4884.4884.4884.48160.00 (Cr)

Sarda Proteins Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
88.7088.7088.7088.70+0.00%
84.4888.7084.4888.70+5.00%
84.4884.4884.4884.48+0.00%
64.6084.4862.2884.48+30.77%
72.0077.6064.6068.00-5.56%
74.1174.1166.8973.93-0.24%
86.0088.6470.9074.11-13.83%
91.1191.1159.9584.42-7.34%
111.75111.7595.9095.90-14.18%
144.30144.30117.60117.60-18.50%
144.30144.30144.30144.30+0.00%
144.30144.30144.30144.30+0.00%

Returns & Performance

Poor

Return on Equity (ROE)

0.42%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

0.84%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-0.07%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Sarda Proteins Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

26.18x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Poor

Promoter Holding

0.00%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

263.64%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

2971.43%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

34.97%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-19.73%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-19.73%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.07x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-0.59 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Sarda Proteins Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SRDAPRT across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Robust Profit Growth (263.64%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (2971.43%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (34.97% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Conservative Debt Levels (D/E: 0.07)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

8 factors identified

Below-Average Return on Equity (0.42%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (0.84%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-0.07%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Weak Earnings Growth (-19.73% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-19.73% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Negative Free Cash Flow (₹-0.59 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (0.00%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Sarda Proteins Ltd vs Edible Oil Peers

Peer Comparison - Edible Oil

Compare Sarda Proteins Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
28.4/100
89
₹13.84
0.42%
Poor
0.84%
Poor
0.1
Excellent
-19.73%
Poor
34.97%
Excellent
0.00%
Marico Ltd...
MARICO531642
56.6/100
834
₹93331.98
56.0
Average
41.34%
Excellent
45.16%
Excellent
0.1
Excellent
9.14%
Good
8.17%
Good
1.46%
60.5/100
455
₹61788.68
43.3
Average
12.06%
Average
15.55%
Good
0.2
Excellent
41.57%
Excellent
21.09%
Excellent
0.59%
34/100
193
₹33161.59
30.6
Average
13.86%
Average
20.89%
Excellent
0.1
Excellent
21.68%
Excellent
16.51%
Excellent
0.00%
61.8/100
235
₹6406.45
21.8
Average
26.95%
Excellent
34.20%
Excellent
0.5
Excellent
66.80%
Excellent
28.47%
Excellent
0.00%
44.8/100
1654
₹3478.93
31.0
Average
4.01%
Poor
6.82%
Poor
0.6
Good
62.43%
Excellent
37.14%
Excellent
0.00%
18.3/100
674
₹2808.03
74.1
Average
3.75%
Poor
0.22%
Poor
0.0
Excellent
2.79%
Average
1.47%
Average
0.00%
63.3/100
254
₹635.93
25.2
Average
20.70%
Excellent
14.57%
Average
2.1
Poor
52.32%
Excellent
24.41%
Excellent
0.35%
45.9/100
194
₹495.60
13.5
Average
11.13%
Average
14.75%
Average
0.1
Excellent
22.89%
Excellent
15.01%
Excellent
0.00%
61.4/100
97
₹398.39
12.6
Average
18.69%
Good
24.46%
Excellent
0.0
Excellent
13.63%
Good
7.13%
Good
0.38%
59.5/100
24
₹239.03
10.9
Average
18.13%
Good
26.76%
Excellent
0.0
Excellent
22.58%
Excellent
11.84%
Good
0.00%

Sarda Proteins Ltd PE Ratio History

Historical price-to-earnings ratio for SRDAPRT — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.11₹113.201029.1x
FY 20221.78₹90.7051x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Sarda Proteins Ltd Quarterly Performance

Latest quarterly metrics for SRDAPRT — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

2971.43%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

263.64%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

34.97%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-19.73%

Compounded annual net profit growth over 5 years

Sarda Proteins Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for SRDAPRT — calculated from daily price history

100RSI 14
Overbought — RSI 100

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
76
▲ Price above SMA 50 — Short-term bullish
SMA 200
80
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
2K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Sarda Proteins Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Sarda Proteins Ltd (SRDAPRT) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Sarda Proteins Ltd

About SRDAPRT (Sarda Proteins Ltd)

Sarda Proteins Ltd is a multifaceted enterprise deeply rooted in the agricultural landscape of India. Specializing in the trade of edible oils, SRDAPRT acts as a vital link in the ...nation's food supply chain. The company expertly navigates the complexities of the commodities market, procuring, processing, and distributing essential cooking oils to meet the diverse culinary needs of Indian consumers. Beyond edible oils, SRDAPRT extends its reach to encompass a broader spectrum of agricultural commodities, demonstrating a commitment to supporting the agrarian economy. This includes the trading of vital oil seeds and grains, which form the bedrock of countless diets across the country. The company's expertise in the agri-commodity sector allows it to adapt to market fluctuations and provide a consistent and reliable source of essential food staples. Diversifying its portfolio, Sarda Proteins Ltd also engages in the trade of mustard oil, a distinctly Indian culinary staple prized for its unique flavor and health benefits. Recognizing the importance of sustainable practices, the company has ventured into the realm of renewable energy, trading in solar cells. This reflects a forward-thinking approach, aligning SRDAPRT with the global movement towards clean energy solutions. By embracing solar energy, the company demonstrates its commitment to environmental responsibility and its dedication to contributing to a greener future. This strategic diversification allows Sarda Proteins to tap into emerging markets and solidify its position as a dynamic and adaptable player in the Indian business landscape. Further broadening its scope, Sarda Proteins Ltd provides manpower services, catering to the evolving needs of various industries. This expansion into human resource solutions underscores the company's adaptability and its commitment to contributing to the overall economic growth of the region. Established in 1991 and headquartered in Alwar, India, SRDAPRT boasts a rich history and a deep understanding of the local market dynamics. With decades of experience, the company has built a strong reputation for reliability, integrity, and a customer-centric approach. Sarda Proteins Ltd continues to evolve, adapt, and innovate, solidifying its position as a key player in the Indian agricultural and energy sectors.

Company Details

Symbol:SRDAPRT
Industry:Edible Oil
Sector:Edible Oil

Key Leadership

Ms. Namrata Karwa
Company Secretary & Compliance Officer
Mr. Chirag Shantilal Thumar
MD & Executive Director
Mr. Yagnik Arvindbhai Satasiya
Chief Financial Officer

SRDAPRT Share Price: Frequently Asked Questions

What is the current share price of Sarda Proteins Ltd?

Sarda Proteins Ltd (SRDAPRT) trades at ₹88.70 on NSE and BSE. Market cap ₹13.84 (Cr). Educational data only.

What is the P/E ratio of Sarda Proteins Ltd?

Sarda Proteins Ltd has a P/E of N/Ax vs industry average 26.18x.

What is the Bull Run score for Sarda Proteins Ltd?

Sarda Proteins Ltd has a Bull Run score of 28.4/100 based on 25+ financial parameters.

Does Sarda Proteins Ltd pay dividends?

Sarda Proteins Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Sarda Proteins Ltd?

Sarda Proteins Ltd has ROE of 0.42%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Sarda Proteins Ltd?

Sarda Proteins Ltd has debt-to-equity of 0.07.

Is Sarda Proteins Ltd a good investment?

Bull Run gives Sarda Proteins Ltd a score of 28.4/100. This is not investment advice — consult a SEBI-registered advisor.